Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis

Microbes and Infection

Volumn 5, Issue 5, 2003, Pages 397-403

  Kieffer, Tara L ^a   Cowley, Siobhan ^a,b   Nano, Francis E ^b   Elkins, Karen L ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF VICTORIA   (Canada)

Author keywords

Francisella tularensis; Immunity, natural; Interleukin 12; Lipopolysaccharide; Macrophages; Tumor necrosis factor

Indexed keywords

BACTERIAL VACCINE; BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; LIVE VACCINE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BONE MARROW; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MEGADOSE; FRANCISELLA; FRANCISELLA NOVICIDA; FRANCISELLA TULARENSIS; IMMUNOBIOLOGY; IMMUNOPATHOGENESIS; LD 50; LETHAL DOSE; MACROPHAGE; MEDIATOR RELEASE; MICROBIAL ACTIVITY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SPECIES COMPARISON; SPECIES DIFFERENCE; SPLEEN CELL;

FRANCISELLA TULARENSIS; FRANCISELLA TULARENSIS SUBSP. NOVICIDA; MURINAE;

EID: 0037989109     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(03)00052-2     Document Type: Article

References (28)

1. Tärnvik A. Nature of protective immunity to Francisella tularensis. Rev. Infect. Dis. 11:1989;440-451.
2. Sanford J.P. Tularemia. JAMA. 250:1983;3225-3226.
3. Eigelsbach H.T., McGann V.G. Genus Francisella Dorofe'ev 1947, 176AL. Kreig N.R. Bergey's Manual of Systematic Bacteriology. 1984;394-399 Williams and Wilkins, Baltimore.
4. Hollis D.G., Weaver R.E., Steigerwalt A.G., Wenger J.D., Moss C.W., Brenner D.J. Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease. J. Clin. Micro. 27:1989;1601-1608.
5. Forsman M., Sandström G., Sjöstedt A. Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR. Int. J. Syst. Bacteriol. 44:1994;38-46.
6. Owen C.R., Buker E.O., Jellison W.L., Lackman D.B., Bell J.F. Comparative studies of Francisella tularensis and Francisella novicida. J. Bacteriol. 87:1964;676-683.
7. Cowley S., Myltseva S., Nano F.E. Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity, and nitric oxide production. Mol. Micro. 20:1996;867-874.
8. Sandström G. The tularemia vaccine. J. Chem. Tech. Biotechnol. 59:1994;315-320.
9. Dreisbach V.C., Cowley S., Elkins K.L. Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon. Infect. Immun. 68:(4):2000;. 1988-196.
10. Baker C.N., Hollis D.G., Thornsberry C. Anti-microbial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth. J. Clin. Micro. 22:1985;212-215.
11. Cowley S.C., Myltseva S.V., Nano F.E. Suppression of Francisella tularensis growth in the rat by co-infection with F. novicida. FEMS Micro. Lett. 153:(1):1997;71-74.
12. Bosio C.M., Elkins K.L. Susceptibility to secondary Francisella tularensis LVS infection in B cell deficient mice is associated with neutrophilia but not with defects in specific T cell mediated immunity. Infect. Immun. 69:2001;194-203.
13. Green L.C., Wagner A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite [15N] nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
14. Elkins K.L., Rhinehart-Jones T.R., Culkin S.J., Yee D., Winegar R.K. Minimal requirements for murine resistance to infection with Francisella tularensis LVS. Infect. Immun. 64:1996;3288-3293.
15. Fortier A.H., Slayter M.V., Ziemba R., Meltzer M.S., Nacy C.A. Live vaccine strain of Francisella tularensis: infection and immunity in mice. Infect. Immun. 59:1991;2922-2928.
16. Rietschel R.T., Kirikae T., Schade F.U., Mamat U., Schmidt G., Loppnow H., Ulmer A.J., Zähringer U., Seydel U., Di Padova F., Schreier M., Brade H. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8:1994;217-225.
17. Sandström G., Sjöstedt A., Johansson T., Kuoppa K., Williams J.C. Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS. FEMS Microbiol. Immunol. 105:1992;201-210.
18. Ancuta P., Pedron R., Girard R., Sandström G., Chaby R. Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins. Infect. Immun. 64:1996;2041-2046.
19. Fulop M., Webber T., Manchee R. Activation of the complement system by Francisella tularensis lipopolysaccharide. Microbiologica. 16:1993;141-148.
20. Fulop M., Manchee R., Titball R. Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia. Vaccine. 13:1995;1220-1225.
21. Anthony L.S.D., Burke R.D., Nano F.E. Growth of Francisella spp. in rodent macrophages. Infect. Immun. 59:1991;3291-3296.
22. Eigelsbach H.T., Downs C.M. Prophylactic effectiveness of live and killed tularemia vaccines. J. Immunol. 87:1961;415-425.
23. Viljanen M.K., Nurmi T., Salminen A. Enzyme-linked immunosorbent assay (ELISA) with bacterial sonicate antigen for IgM, IgA, and IgG antibodies to Francisella tularensis: comparison with bacterial agglutination test and ELISA with lipopolysaccharide antigen. J. Infect. Dis. 148:1983;715-720.
24. Rhinehart-Jones T.R., Fortier A.H., Elkins K.L. Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells. Infect. Immun. 62:1994;3129-3137.
25. Elkins K.L., MacIntyre A.T., Rhinehart-Jones T.R. Nonspecific early protective immunity in Francisella and Listeria infections can be dependent on lymphocytes. Infect. Immun. 66:1998;3467-3469.
26. Elkins K.L., Leiby D.A., Winegar R.K., Nacy C.A., Fortier A.H. Rapid generation of specific protective immunity to Francisella tularensis. Infect. Immun. 60:1992;4571-4577.
27. Elkins K.L., Rhinehart-Jones T.R., Nacy C.A., Winegar R.K., Fortier A.H. T-cell-independent resistance to infection and generation of immunity to Francisella tularensis. Infect. Immun. 61:1993;823-829.
28. Culkin S.J., Rhinehart-Jones T.R., Elkins K.L. A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J. Immunol. 158:1997;3277-3284.